Early heart unloading for severe shock after ECMO
Part of Heart & circulation clinical trials.
This trial tests a possible treatment to help the heart recover faster in people who need ECMO support for severe cardiogenic shock (when the heart can't pump enough blood). The treatment involves early use of a device to reduce pressure on the heart's main pumping chamber.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been on a special machine called VA-ECMO to support your heart for severe shock for less than 24 hours.
- A doctor must be able to start heart-unloading treatment within 12 hours after you agree to be in the study.
- You must have a family member or legal representative who can give permission if you cannot; if not, special emergency consent rules may apply.
- You must have French social security coverage.
- You must be 18 years or older and not pregnant.
- You cannot have had other heart support devices like a balloon pump or Impella before joining the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study will look at whether “left ventricular unloading” (using a device like IABP or Impella) helps people who are in cardiogenic shock while on VA ECMO. It compares outcomes for people who get unloading versus those who stay on VA ECMO alone.
This trial tests if unloading the heart during ECMO support helps patients recover better from cardiogenic shock. It compares different ways to reduce the heart's workload.
This trial studies whether using a life-support machine called ECMO (extra support for the heart and lungs) helps people who develop shock right after a heart attack. It aims to improve outcomes when blood flow is failing and organs may be struggling.
This trial tests if using a heart pump (IABP) early after starting a life support machine (VA-ECMO) helps people recover from cardiogenic shock. It looks for patients whose heart is not pumping well despite support.
This trial studies whether an “early” or more “conservative” approach to improving blood flow to the leg can prevent limb damage during a type of heart-lung machine called peripheral VA-ECMO. It may help reduce the risk of poor leg blood flow (ischemia) in people with severe heart failure-related shock.
This study looks at how to best relieve pressure on the heart while a heart-lung machine is helping to pump blood. It includes anyone who needs this support.
Hear when a new Cardiogenic Shock Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.